Epileptic Seizure in Epilepsy Patients After SARS-CoV-2 Vaccination

Clinical trial NCT05341713 · COMPLETED

Trial details

NCT number: NCT05341713
Sponsor: Xijing Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Epileptic Seizures Related to Drugs SARS-CoV-2 Acute Respiratory Disease Vaccine Adverse Reaction

Start date: 2022-01-01
Primary completion: 2022-04-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.